Ginkgo Bioworks Holdings (DNA) Change in Cash (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Change in Cash data on file, last reported at -$23.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 90.53% year-over-year to -$23.7 million; the trailing twelve-month figure through Mar 2026 stood at -$166.7 million (up 68.65% YoY), and the FY2025 full-year result was -$393.4 million, down 2.48% from the prior year.
• Change in Cash for Q1 2026 stood at -$23.7 million, down from $55.4 million in the prior quarter.
• Across five years, Change in Cash topped out at $55.4 million in Q4 2025 and bottomed at -$250.3 million in Q1 2025.
• The 5-year median for Change in Cash is -$94.4 million (2025), against an average of -$82.6 million.
• The widest annual swing landed in 2023, when Change in Cash plunged 536.35%; it then surged 199.31% in 2025.
• A 5-year view of Change in Cash shows it stood at $24.1 million in 2022, then slumped by 536.35% to -$105.0 million in 2023, then soared by 46.88% to -$55.8 million in 2024, then soared by 199.31% to $55.4 million in 2025, then slumped by 142.77% to -$23.7 million in 2026.
• The last three Change in Cash figures came in at -$23.7 million (Q1 2026), $55.4 million (Q4 2025), and -$94.4 million (Q3 2025), per Business Quant data.

Peer Comparison